跳至主要内容
临床试验/CTRI/2013/11/004139
CTRI/2013/11/004139招募中3 期

Individualized Homoeopathic intervention in Diabetic Foot Ulcer: a Randomised controlled pilot study using Calendula Q vs normal saline for ulcer dressing

Central Council of Research in Homoeopathy0 个研究点目标入组 60 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
招募中
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • i.Men and women aged 18 to 70 years, extremes included with Type 1 or Type 2 Diabetes Mellitus on standard conventional treatment
  • ii.Single diabetic foot ulcer at or below the malleoli
  • iii.Diabetic foot ulcer Wegnar 1-2 stage
  • iv.Chronic ulcer of at least four weeks duration but not more than 3 months
  • v.Ulcer size (greatest length by greatest width) at randomization between 1.0 cm2 to 10 cm2, both inclusive.
  • vi.Adequate arterial blood supply, to be measured by (color) doppler ultrasonography, ankle brachial pressure index 0.60, or ankle systolic pressure 70 mmHg or toe pressure 30 mmHg
  • vii.Peripheral neuropathy as assessed by Semmes-Weinstein monofilament test
  • viii.HbA1C <= 8%
  • ix.Controlled Hypertension
  • x.Women surgically sterile, post-menopausal, or agree to practice adequate contraception.
  • xi.Written Informed consent from the patient
  • The patients shall continue to take standard allopathic treatment for Diabetes Mellitus and hypertension (in consultation with consultant engaged in study).

排除标准

  • i.Wagner grade 0, 3, 4 and grade 5
  • ii.Cases presenting with long term complication of diabetes such as severe retinopathy, severe renal involvement or with history of recurrent acute complications like hypoglycemia, ketoacidosis, polyneuropathy etc.
  • iii.Alcohol addiction or dependence
  • iv.Subjects with ill managed diabetes i.e. glycosylated hemoglobin (HbA1c) more than 8%.
  • v.Cases with severe coronary, cerebral, renal vascular, liver diseases as well as malignant neoplasms
  • vi.Subjects deemed unfit by the investigator.

研究者

发起方
Central Council of Research in Homoeopathy

相似试验